Home Cart 0 Sign in  
X

[ CAS No. 53844-02-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 53844-02-3
Chemical Structure| 53844-02-3
Chemical Structure| 53844-02-3
Structure of 53844-02-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 53844-02-3 ]

Related Doc. of [ 53844-02-3 ]

Alternatived Products of [ 53844-02-3 ]

Product Details of [ 53844-02-3 ]

CAS No. :53844-02-3 MDL No. :MFCD09909490
Formula : C10H12BrNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :HREXFDIZSAUXBO-UHFFFAOYSA-N
M.W : 258.11 Pubchem ID :278694
Synonyms :

Calculated chemistry of [ 53844-02-3 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 6
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 58.17
TPSA : 38.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.56
Log Po/w (XLOGP3) : 2.44
Log Po/w (WLOGP) : 2.16
Log Po/w (MLOGP) : 2.24
Log Po/w (SILICOS-IT) : 2.17
Consensus Log Po/w : 2.31

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.9
Solubility : 0.326 mg/ml ; 0.00126 mol/l
Class : Soluble
Log S (Ali) : -2.89
Solubility : 0.334 mg/ml ; 0.00129 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.21
Solubility : 0.016 mg/ml ; 0.0000619 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.19

Safety of [ 53844-02-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 53844-02-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 53844-02-3 ]
  • Downstream synthetic route of [ 53844-02-3 ]

[ 53844-02-3 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 2576-47-8 ]
  • [ 501-53-1 ]
  • [ 53844-02-3 ]
YieldReaction ConditionsOperation in experiment
99% With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; for 13.33 h; Inert atmosphere A cooled (0° C.) mixture of 2-bromoethylamine hydrobromide (12.000 g ; 58.56 mmol ; 1.0 eq.) in dioxane (60 ml) was treated with aq. 1M NaOH (117.2 ml ; 117.20 mmol ; 2.0 eq.), and dropwise (over 10 min.) with benzyl chloroformate (8.4 ml ; 58.8 mmol ; 1.0 eq.). The resulting mixture was further stirred at 0° C., under nitrogen, for 10 min., and then at rt for 13 h. Et2O (300 ml) was added, and the colorless organic layer was further washed with water (75 ml), dried over anh. MgSO4, filtered, and finally concentrated to dryness under reduced pressure to afford (2-bromo-ethyl)-carbamic acid benzyl ester as a colorless oil which was further dried under HV (15.020 g ; 99percent). LC-MS: tR=0.95 min. ; [M+H]+: no ionisation.
99% With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; for 13.3333 h; Inert atmosphere B.3 /V-alkylation of imidazoles with Br(CH2^NHBoC or with (2-bromo-ethyl)-carbamic acid benzyl ester; Preparation of (2-bromo-ethyl)-carbamic acid benzyl ester; A cooled (00C) mixture of 2-bromoethylamine hydrobromide (12.000 g; 58.56 mmol; 1.0 eq.) in dioxane (60 ml) was treated with aq. 1 M NaOH (117.2 ml; 117.20 mmol; 2.0 eq.), <n="50"/>and dropwise (over 10 min.) with benzyl chloroformate (8.4 ml; 58.8 mmol; 1.0 eq.). The resulting mixture was further stirred at 00C, under nitrogen, for 10 min., and then at rt for 13h. Et2O (300 ml) was added, and the colorless organic layer was further washed with water (75 ml), dried over anh. MgSO4, filtered, and finally concentrated to dryness under reduced pressure to afford (2-bromo-ethyl)-carbamic acid benzyl ester as a colorless oil which was further dried under HV (15.020 g; 99percent). LC-MS: tR = 0.95 min.; [M+H]+: no ionisation.
95% With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; Treat a 0 °C solution of 2-bromoethylamine hydrobromide (50 g, 0.246 mol) in dioxane (500 mL) with aqueous NaOH (1 M, 492 mL, 0.492 mol), add benzyl chloroformate (21.6 g, 0.127 mol) drop-wise, warm to RT and stir overnight. Pour the mixture into H20, extract with EtOAc (3X), wash the combined organics with brine, dry over Na2S04, concentrate to dryness and purify via silica gel chromatography (EtOAc/Petroleum ether) to afford the title compound (60 g, 95percent) as a white solid. 1H NMR (400 MHz, CDC13): δ 7.37-7.33 (m, 5 H), 5.12 (s, 2 H), 3.61 (t, J = 5.6 Hz, 2 H), 3.47 (t, J= 5.6 Hz, 2 H).
87% With triethylamine In ethanol at 20℃; for 20 h; General Synthesis Instructions for N-Z-2-bromoethylamine/N-Z-3-bromopropylamine: Add a solution of 1.5 equivalents of benzylchloroformiate in 50 ml Rotisol in drops to a solution of one equivalent of 2-bromoethylamine-hydrobromide or 3-bromopropylamine-hydrobromide and three equivalents of triethylamine in 150 ml Rotisol under refrigeration. Stir for 20 hours at room temperature, then concentrate the formulation to a small volume, take it up in 200 ml ethyl acetate, and extract twice against 200 ml 2 N hydrochloric acid each time. Remove the solvent and purify the residue via column chromatography on 100 g silica gel. Elute the apolar impurities with cyclohexane/diisopropyl ether (10:1), and elute the product with diisopropyl ether; N-Z-2-bromoethylamine (72): Quantities Used: 34.8 g (170 mmol) 2-bromoethylamine-hydrobromide, 72.0 ml (255 mmol) 50percent solution of benzylchloroformiate in toluene, 70.6 ml (510 mmol) triethylamine
64% With N-ethyl-N,N-diisopropylamine In DMF (N,N-dimethyl-formamide) at 20℃; for 2 h; To a solution of 2-bromoethylamine bromide (5 g, 24.4 mmole) in DMF (50 mL) was added diisopropylethylamine (8.5 mL, 48.8 mmole) and benzyl chloroformate (3.48 mL, 24.4 mmole). The mixture thus obtained was stirred at room temperature for 2 hours. The reaction mixture was concentrated and the residue was purified by flash chromatography on silica gel with ethyl acetate/hexanes (3/7) as eluent to give the desired compound 34 as an oil (4 g, 64percent). 1H NMR (CDCl3) No. 3.54 (bs, 2H), 3.61 (bs, 2H), 5.12 (s, 2H), 7.36 (m, 5H).
64% With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 2 h; Synthesis of Compound 1: To a solution of 2-bromoethylamine bromide (5 g, 24.4 mmole) in DMF (50 mL) was added diisopropylethylamine (8.5 mL, 48.8 mmole) and benzyl chlroroformate (3.48 mL, 24.4 mmole). The mixture thus obtained was stirred at room temperature for 2 hours. The reaction mixture was concentrated and the residue was purified by flash chromatography on silica gel with ethyl acetate/hexanes (3/7) as gradient to give Compound 1 as an oil (4 g, 64percent). 1H NMR (CDCl3) δ 3.54 (bs, 2H), 3.61 (bs, 2H), 5.12 (s, 2H), 7.36 (m, 5H).

Reference: [1] Journal of Medicinal Chemistry, 1981, vol. 24, # 4, p. 408 - 428
[2] Patent: US2011/105514, 2011, A1, . Location in patent: Page/Page column 21
[3] Patent: WO2009/156951, 2009, A2, . Location in patent: Page/Page column 47-48
[4] Chemical Communications, 2010, vol. 46, # 17, p. 2983 - 2985
[5] Journal of Organic Chemistry, 2000, vol. 65, # 26, p. 8979 - 8987
[6] Patent: WO2013/134298, 2013, A1, . Location in patent: Page/Page column 62
[7] Journal of Medicinal Chemistry, 1991, vol. 34, # 9, p. 2816 - 2821
[8] Inorganic Chemistry, 2017, vol. 56, # 11, p. 6429 - 6437
[9] European Journal of Organic Chemistry, 2005, # 3, p. 487 - 495
[10] Patent: WO2005/3105, 2005, A1, . Location in patent: Page 13; Fig. 6
[11] Patent: US2003/229037, 2003, A1, . Location in patent: Page/Page column 55, 21
[12] Chemical Communications, 2013, vol. 49, # 25, p. 2560 - 2562
[13] Organic Letters, 2008, vol. 10, # 5, p. 793 - 796
[14] Farmaco, 2003, vol. 58, # 9, p. 917 - 928
[15] Patent: WO2005/112919, 2005, A2, . Location in patent: Page/Page column 160
[16] Patent: US2010/145036, 2010, A1, . Location in patent: Page/Page column 54; 56; 58; 61
[17] Journal of Organic Chemistry, 1997, vol. 62, # 20, p. 6754 - 6759
[18] Journal of Medicinal Chemistry, 2007, vol. 50, # 11, p. 2605 - 2608
[19] Patent: US6627651, 2003, B1,
[20] Patent: EP976722, 2000, A1,
[21] Patent: EP1182195, 2002, A1, . Location in patent: Example 99'
[22] Patent: US2010/152265, 2010, A1, . Location in patent: Page/Page column 53
[23] Patent: US2010/160256, 2010, A1, . Location in patent: Page/Page column 67
[24] Journal of Medicinal Chemistry, 2010, vol. 53, # 13, p. 4877 - 4890
[25] Chemical Communications, 2009, # 40, p. 6044 - 6046
[26] Patent: EP2447264, 2012, A1, . Location in patent: Page/Page column 171-172
[27] Journal of Medicinal Chemistry, 2015, vol. 58, # 10, p. 4194 - 4203
[28] Patent: CN107673957, 2018, A, . Location in patent: Paragraph 0050-0052
[29] Patent: WO2008/103693, 2008, A2, . Location in patent: Page/Page column 75
  • 2
  • [ 107-09-5 ]
  • [ 501-53-1 ]
  • [ 53844-02-3 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 2, p. 568 - 571
[2] Journal of Organic Chemistry, 1950, vol. 15, p. 1067,1071
[3] Australian Journal of Chemistry, 1959, vol. 12, p. 296
[4] Patent: US4804684, 1989, A,
[5] Patent: US2006/3970, 2006, A1, . Location in patent: Page/Page column 10-11
  • 3
  • [ 134307-72-5 ]
  • [ 53844-02-3 ]
Reference: [1] Advanced Synthesis and Catalysis, 2012, vol. 354, # 8, p. 1519 - 1528
[2] Chemistry - A European Journal, 1998, vol. 4, # 1, p. 137 - 151
[3] Patent: EP918790, 2004, B1, . Location in patent: Page 7; 11; 52
[4] Journal of Organic Chemistry, 2010, vol. 75, # 16, p. 5757 - 5759
  • 4
  • [ 13139-17-8 ]
  • [ 2576-47-8 ]
  • [ 53844-02-3 ]
Reference: [1] Patent: WO2005/30209, 2005, A1, . Location in patent: Page/Page column 50
  • 5
  • [ 58861-74-8 ]
  • [ 501-53-1 ]
  • [ 53844-02-3 ]
Reference: [1] Patent: US6037362, 2000, A,
  • 6
  • [ 501-53-1 ]
  • [ 53844-02-3 ]
Reference: [1] Patent: EP976722, 2000, A1,
  • 7
  • [ 2304-94-1 ]
  • [ 53844-02-3 ]
Reference: [1] Tetrahedron, 1987, vol. 43, # 13, p. 2977 - 2984
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 53844-02-3 ]

Aryls

Chemical Structure| 39945-54-5

[ 39945-54-5 ]

Benzyl (3-bromopropyl)carbamate

Similarity: 0.89

Chemical Structure| 72080-83-2

[ 72080-83-2 ]

Benzyl (2-aminoethyl)carbamate

Similarity: 0.87

Chemical Structure| 18807-71-1

[ 18807-71-1 ]

Benzyl N-(2-aminoethyl)carbamate hydrochloride

Similarity: 0.85

Chemical Structure| 46460-73-5

[ 46460-73-5 ]

Benzyl (3-aminopropyl)carbamate

Similarity: 0.85

Chemical Structure| 277328-34-4

[ 277328-34-4 ]

1-Cbz-Amino-2-methylaminoethane hydrochloride

Similarity: 0.85

Bromides

Chemical Structure| 39945-54-5

[ 39945-54-5 ]

Benzyl (3-bromopropyl)carbamate

Similarity: 0.89

Chemical Structure| 340187-12-4

[ 340187-12-4 ]

(9H-Fluoren-9-yl)methyl (2-bromoethyl)carbamate

Similarity: 0.82

Chemical Structure| 186663-83-2

[ 186663-83-2 ]

(9H-Fluoren-9-yl)methyl (3-bromopropyl)carbamate

Similarity: 0.75

Chemical Structure| 159275-17-9

[ 159275-17-9 ]

Benzyl 4-(Bromomethyl)tetrahydro-1(2H)-pyridinecarboxylate

Similarity: 0.75

Chemical Structure| 799767-82-1

[ 799767-82-1 ]

Benzyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate

Similarity: 0.69

Amides

Chemical Structure| 39945-54-5

[ 39945-54-5 ]

Benzyl (3-bromopropyl)carbamate

Similarity: 0.89

Chemical Structure| 72080-83-2

[ 72080-83-2 ]

Benzyl (2-aminoethyl)carbamate

Similarity: 0.87

Chemical Structure| 18807-71-1

[ 18807-71-1 ]

Benzyl N-(2-aminoethyl)carbamate hydrochloride

Similarity: 0.85

Chemical Structure| 46460-73-5

[ 46460-73-5 ]

Benzyl (3-aminopropyl)carbamate

Similarity: 0.85

Chemical Structure| 277328-34-4

[ 277328-34-4 ]

1-Cbz-Amino-2-methylaminoethane hydrochloride

Similarity: 0.85

Amines

Chemical Structure| 39945-54-5

[ 39945-54-5 ]

Benzyl (3-bromopropyl)carbamate

Similarity: 0.89

Chemical Structure| 72080-83-2

[ 72080-83-2 ]

Benzyl (2-aminoethyl)carbamate

Similarity: 0.87

Chemical Structure| 18807-71-1

[ 18807-71-1 ]

Benzyl N-(2-aminoethyl)carbamate hydrochloride

Similarity: 0.85

Chemical Structure| 46460-73-5

[ 46460-73-5 ]

Benzyl (3-aminopropyl)carbamate

Similarity: 0.85

Chemical Structure| 277328-34-4

[ 277328-34-4 ]

1-Cbz-Amino-2-methylaminoethane hydrochloride

Similarity: 0.85